2FEIZI T. Immunoglobulins in chronic liver disease[ J]. Gut, 1968,9 (2) :193.
3VERBAAN H ,BONDESON L, ERIKSSON S. Non-invasive assessment of inflammatory activity and fibrosis (grade and stage)in chronic hepatitis C infection[ J]. Scand J Gastroenterol,1997,32(5) :494.
4SCHMILOVITZ-WEISS H,TOVAR A, HALPERN M,et al. Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection [ J ]. J Viral Hepat, 2006,13 (10) :671.
5Albanopoulos-K, Armakolas-A, Konstadoulakis-MM, et al. Prognostic significance of circulating antibodies against carcinomebryonic antigen (anti-CEA) in patients with colon cancer[J]. Am J Gastroenterol.,2000,95(4): 1056- 61.
6Tomeczko-J,Napora-p,Dlubek-D, et al. Adjuvant spleen ultrafiltrate immunotherapy in unresectable advanced non small cell lung cancer [J]. Arzneimittelforschung, 1997, 47(12):1411 - 1416.
7Fujita-T; Hara-A; Yamazaki-Y. The value of acute-phase protein measurements after curative gastric cancer surgery [J]. Arch Surg, 1999,134 (1): 73 - 75.
8Simonetti RG. Hepatocellular carcinoma: a worldwide problem and the major risk factors [J]. Dig Sci, 1991,36 (5):962.
10Verbaan H,Bondeson L,Eriksson S.Non-invasive assessment of inflammatory activity and fibrosis(grade and stage)in chronie hepatitis C infection[J].Scand J Gastroenterol.1997.32(5):494-499.
